Search Browse Earnings

Tvardi Therapeutics, Inc.

Nasdaq:TVRD

Pharmaceutical Preparations·SUGAR LAND, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$41.9M

+81.8% YoY

FY 2024

Adj. EBITDA

-$87.3M

-208.5% margin

FY 2024

Net Income

-$85.5M

-204.2% margin

FY 2024

EPS (Diluted)

-$19.12

FY 2024

Stock Price

$3.85

-3.3%

2026-03-10

52W Range

$3.50 – $43.65

P/E Ratio

-0.2x

Market Cap

$36.1M

Cash

$51.8M

FY 2024

Total Debt

—

Net Cash

$51.8M

FY 2024

Enterprise Value

-$15.7M

Debt / EBITDA

0.6x

FY 2024

EV / EBITDA

0.2x

Employees

—